Paying for modern cancer care--a global perspective.
Rawlins
Michael
M
National Institute for Health and Clinical Excellence, London and London School of Hygiene and Tropical Medicine, London, UK.
D000970:Antineoplastic Agents / Q000191:economics; D003362:Cost-Benefit Analysis; D003906:Developing Countries; D016527:Drug Costs; D017048:Health Care Costs; D006296:Health Services / Q000191:economics; D006801:Humans; D009369:Neoplasms / Q000191:economics* / Q000628:therapy*; D040841:Resource Allocation; D006113:United Kingdom
D000970:Antineoplastic Agents